Microbia Announces Name Change to Ironwood Pharmaceuticals

Apr 07, 2008, 01:00 ET from Microbia, Inc.

    CAMBRIDGE, Mass., April 7, 2008 /PRNewswire/ -- Microbia, Inc. today
 announced that it has changed its name to Ironwood Pharmaceuticals, Inc.
 The ironwood is a long-lived tree that thrives in the harshest desert
 environment, with some trees surviving as long as 1,500 years. Known as a
 "nurse tree," it provides a shaded microclimate with lower temperatures,
 higher water availability, and more organic matter for birds, reptiles,
 insects, animals, and plants. In addition, the name Ironwood encompasses
 the inorganic and organic -- the properties of essential elements and the
 characteristics of life.
     "As Microbia has developed and progressed, we have outgrown the
 usefulness of the name Microbia," said Peter Hecht, CEO. "With that in
 mind, we sought a name for the company that reflects our approach to
 creating important human medicines. Because our research efforts are not
 limited to a single therapeutic area, we require a name that will
 accommodate a broad range of discoveries and products. We chose a name that
 not only suits us today, but also can endure for 100 years."
     Additional information can be found at http://www.ironwoodpharma.com.
     About Ironwood Pharmaceuticals (formerly Microbia)
     Ironwood Pharmaceuticals (http://www.ironwoodpharma.com) is an
 entrepreneurial pharmaceutical company dedicated to the art and science of
 great drugmaking. The Company is advancing several clinical candidates --
 linaclotide for the treatment of irritable bowel syndrome with
 constipation, chronic constipation and other functional gastrointestinal
 disorders; and novel, next-generation cholesterol absorption inhibitors for
 the treatment of hypercholesterolemia. Ironwood also has a growing pipeline
 of additional drug candidates in earlier stages of development. Microbia
 Precision Engineering, Inc., a majority-owned subsidiary of Ironwood
 Pharmaceuticals is an industrial biotechnology company developing and
 commercializing novel bioprocesses for the production of specialty
 chemicals. Ironwood has raised $231 million in private equity financing and
 is located in Cambridge, Massachusetts.
Contact: Susan Brady Corporate Communications 617|621-8304 sbrady@ironwoodpharma.com

SOURCE Microbia, Inc.